Hollencrest Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Hollencrest Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,995	Closed	-$35K	–	378
2016 Q3	$35K	Buy	1,995 +75	+4%	+$1.24K	0.01%	357
2016 Q2	$33K	Hold	1,920	–	–	0.01%	410
2016 Q1	$38K	Hold	1,920	–	–	0.01%	392
2015 Q4	$37K	Hold	1,920	–	–	0.01%	399
2015 Q3	$37K	Hold	1,920	–	–	0.01%	390
2015 Q2	$89K	Hold	1,920	–	–	0.01%	405
2015 Q1	$84K	Hold	1,920	–	–	0.01%	426
2014 Q4	$67K	Buy	1,920 +50	+3%	+$2.03K	0.01%	428
2014 Q3	$78K	Hold	1,870	–	–	0.01%	411
2014 Q2	$110K	Hold	1,870	–	–	0.01%	407
2014 Q1	$118K	Hold	1,870	–	–	0.02%	410
2013 Q4	$109K	Buy	+1,870	New	+$97.7K	0.02%	344

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Hollencrest Capital Management's ARNA Position: Q4 2016 in Review

Hollencrest Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2016, closing a stake of 1,995 shares — an estimated $35K sold.

Hollencrest Capital Management first reported a position in ARNA in Q4 2013 and held it in 12 quarters. The position peaked at $118K in Q1 2014. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

Hollencrest Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Hollencrest Capital Management sold 1,995 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $35K.
Hollencrest Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 12 quarters.
Hollencrest Capital Management's Arena Pharmaceuticals Inc position peaked at $118K in Q1 2014.
128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on Hollencrest Capital Management's 13F filing for Q4 2016, filed 30 Jan 2017.